Get the Stockscreener App
1.29
21.70%
0.23
After Hours:
1.30
0.01
+0.78%
Ispecimen Inc stock is traded at $1.29, with a volume of 1.87M.
It is up +21.70% in the last 24 hours and up +37.44% over the past month.
iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research, with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas; Europe, the Middle East, Africa, and Asia Pacific, which majority, comes from the Americas.
See More
Previous Close:
$1.06
Open:
$1.07
24h Volume:
1.87M
Relative Volume:
16.19
Market Cap:
$3.22M
Revenue:
$10.39M
Net Income/Loss:
$-9.52M
P/E Ratio:
-0.0675
EPS:
-19.12
Net Cash Flow:
$-6.02M
1W Performance:
+15.18%
1M Performance:
+37.44%
6M Performance:
-38.28%
1Y Performance:
-76.20%
1-Day Range:
$1.03
$1.3696
1-Week Range:
$0.90
$1.3696
52-Week Range:
$0.855
$8.30
Ispecimen Inc Stock (ISPC) Company Profile
Name
Ispecimen Inc
Sector
Industry
Phone
781-301-6700
Address
8 CABOT ROAD, WOBURN
Compare ISPC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ISPC
Ispecimen Inc
|
1.29 | 2.65M | 10.39M | -9.52M | -6.02M | -19.12 |
|
TMO
Thermo Fisher Scientific Inc
|
477.28 | 182.01B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
203.99 | 148.12B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
572.09 | 46.09B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
118.05 | 34.04B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
191.54 | 33.07B | 15.50B | 1.33B | 2.16B | 7.34 |
Ispecimen Inc Stock (ISPC) Latest News
Is iSpecimen Inc. stock a good hedge against inflationEarly Buy Opportunity with Chart Triggers - Newser
Will iSpecimen Inc. benefit from macro trendsPredictable Income Summary for Long-Term Trades - Newser
What makes iSpecimen Inc. stock price move sharplyFree Low Capital High Return Stock Plans - Newser
Custom strategy builders for tracking iSpecimen Inc.Free AI Screening for Swing Trade Picks - Newser
Price action breakdown for iSpecimen Inc.Free Trade Setups With AI Powered Filters - Newser
What institutional flow reveals about iSpecimen Inc.Free Sector Based Breakout Stock Forecast - Newser
iSpecimen Inc. stock chart pattern explainedAlpha Stock Picks with Chart Confirmation - Newser
Key resistance and support levels for iSpecimen Inc.Free Growth Based Investment Plan Guidance - Newser
Is iSpecimen Inc. stock a growth or value playFree Real-Time Analysis With Entry Targets - Newser
How iSpecimen Inc. stock performs during market volatilityMachine Learning Stock Price Forecast Tool - Newser
Why iSpecimen Inc. stock attracts strong analyst attentionFree Daily Top Performing Stock Insights - Newser
What is the risk reward ratio of investing in iSpecimen Inc. stockChart Pattern Strategy To Watch Now - jammulinksnews.com
iSpecimen prices $4 million public offering at $0.70 per share By Investing.com - Investing.com Nigeria
iSpecimen prices $4 million public offering at $0.70 per share - Investing.com
Correction: iSpecimen Inc. Announces Closing of $4 Million Underwritten Offering - MarketScreener
iSpecimen Secures $4M in Fresh Capital: Here's How They'll Spend Every Dollar - Stock Titan
Biospecimen Marketplace iSpecimen Raises $4M: Here's How They'll Spend It - Stock Titan
How does iSpecimen Inc. compare to its industry peersHigh-velocity gains - jammulinksnews.com
Using RSI to spot recovery in iSpecimen Inc.Trading Opportunities Forecast by AI Insight - Newser
iSpecimen Inc. Stock Performance After Earnings: Historical InsightsFree Accurate Buy Point for Momentum Stocks - Newser
Does iSpecimen Inc. stock perform well during market downturnsGet exclusive market analysis for investors - jammulinksnews.com
How does iSpecimen Inc. generate profit in a changing economyConsistently high yield - jammulinksnews.com
Is iSpecimen Inc. stock overvalued or undervaluedBuild a diversified portfolio for risk management - jammulinksnews.com
iSpecimen's $4M Raise: Strategic Allocation or a Sign of Financial Strain? - AInvest
Is iSpecimen Inc. a good long term investmentHigh-velocity gains - PrintWeekIndia
iSpecimen Completes Public Offering to Raise $4 Million - TipRanks
ISpecimen Completes $4 Million Underwritten Offering - MarketScreener
iSpecimen Inc. Closes $4 Million Public Offering of Common Stock - Quiver Quantitative
iSpecimen Announces Completion of $4 Million Underwritten Offering, Plans to Use Proceeds for Marketing, Advertising, and Working Capital - AInvest
ISpecimen Inc. Announces Closing of $4 Million Underwritten Offering - MarketScreener
iSpecimen Raises $4M in Public Offering: Here's How the Biotech Marketplace Plans to Expand - Stock Titan
What drives iSpecimen Inc. stock priceRecord-setting profit potential - PrintWeekIndia
What analysts say about iSpecimen Inc. stockExceptional gains - PrintWeekIndia
iSpecimen announces pricing of $4M underwritten offering - MSN
Is iSpecimen Inc. stock overhyped or has real potentialRapid market gains - jammulinksnews.com
Ispecimen Inc Stock (ISPC) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.36%
0.48%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):